VHL peptide product blog
Tags: VHL; Peptide; VHL peptide;
The VHL vhl (Catalog #MBS425534) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase. The VHL Immunizing Peptide reacts with Human, Mouse, Rat, Dog and may cross-react with other species as described in the data sheet.The VHL vhl product has the following accession number(s) (GI #4507891) (NCBI Accession #NP_000542.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful. The amino acid sequence is listed below:
C-RSLVKPEN YRRLD.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Brain Diseases, Carcinoma, Carcinoma, Renal Cell, Cardiovascular Diseases, Chromosome Aberrations, Death, Kidney Diseases, Kidney Neoplasms, Pheochromocytoma, von Hippel-Lindau Disease are some of the diseases may be linked to VHL Immunizing Peptide. VHL also interacts with the following gene(s): CUL2, EGLN1, EPAS1, HIF1A, HIF3A, RBX1, TCEB1, TCEB2, UBC. The following patways have been known to be associated with this gene. Blood, Bone, Brain, Eye, Kidney, Liver, Lung, Pancreas, Thyroid, Vascular tissues are correlated with this protein.